other material
confidence high
sentiment neutral
materiality 0.70
Klotho Neurosciences raises ~$15M via sale of Series C convertible preferred stock to Sigma9 Capital
Greenland Mines Ltd
- Sold 3,400 shares of Series C Preferred at $4,400/share to Sigma9 Capital Ltd for total proceeds of ~$15.0M.
- Each share convertible into 10,000 common shares, subject to 9.99% beneficial ownership cap and Nasdaq stockholder approval if needed.
- Conversion terms potentially add up to 34M shares of common stock upon conversion (dilutive).
- Closing expected by December 31, 2025; no underwriters, no commissions, relying on Section 4(2) exemption.